BIOLIFE SOLUTIONS INC (BLFS) Insider Trading Disclosures
BIOLIFE SOLUTIONS INC (BLFS) is a publicly traded company on the Nasdaq, categorized under SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BLFS
CIK: 834365
Exchange: Nasdaq
SIC 3845: Electromedical & Electrotherapeutic Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerChristopher Morgan
Audit LocationBellevue, Washington, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 15-12G | 2026-10-16 | — | 15-12G | 0001193125-26-424049 | View SEC Doc Filr Page |
| EFFECT | 2026-10-09 | — | EFFECT Filing | 9999999995-26-003195 | View SEC Doc Filr Page |
| EFFECT | 2026-10-09 | — | EFFECT Filing | 9999999995-26-003194 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418329 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418328 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418327 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418325 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418323 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418321 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418319 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418316 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418315 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418308 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418304 | View SEC Doc Filr Page |
| S-8 POS | 2026-10-06 | — | S-8 POS | 0001193125-26-415573 | View SEC Doc Filr Page |
| S-8 POS | 2026-10-06 | — | S-8 POS | 0001193125-26-415563 | View SEC Doc Filr Page |
| S-8 POS | 2026-10-06 | — | S-8 POS | 0001193125-26-415549 | View SEC Doc Filr Page |
| POS AM | 2026-10-06 | — | POS AM | 0001193125-26-415533 | View SEC Doc Filr Page |
| POS AM | 2026-10-06 | — | POS AM | 0001193125-26-415526 | View SEC Doc Filr Page |
| 25-NSE | 2026-10-06 | — | 25-NSE Filing | 0001354457-26-000952 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-06 | 8-K | 0001193125-26-415012 | View SEC Doc Filr Page |
| 425 | 2026-09-30 | — | 425 | 0001193125-26-408201 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-30 | — | DEFA14A | 0001193125-26-408198 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-24 | — | SCHEDULE 13G Filing | 0001076809-26-000101 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | FORM 4 | 0001628280-26-063079 | View SEC Doc Filr Page |